What are the legal risks of importing and possessing peptides in Poland, Czechia, Romania, Greece and the rest of Central & Eastern Europe?

The short answer

This is the region where peptide law is genuinely dangerous, and where the reputations are backwards. Romania punishes bringing listed peptides into the country with two to seven years' imprisonment — a more severe offence than domestic trafficking, with no carve-out for movement from another EU country. Czechia criminalises possession above a threshold of more than one vial or blister, the lowest in Europe. Meanwhile Poland, Hungary, Romania, Slovenia and Croatia do not criminalise personal possession at all.

And BPC-157 falls through the gaps. It sits in WADA class S0, which places it outside the criminal doping provisions in several of these countries while remaining an unauthorised medicine — a different and softer legal problem.

Evidence tier: Tier 1 for statutes read directly, and the report behind this page names which were opened. Several items are marked unverified and should be checked before anyone relies on them. Educational content, not legal advice.

The key points:

• Romania: 2–7 years for unauthorised import of listed substances, harsher than trafficking.
• Czechia: criminal possession above one vial or blister — the lowest threshold found.
• Poland: importing a WADA S1/S2/S4 substance outside the pharmacy route is a criminal offence, up to 3 years.
• Greece's severe doping law mostly does not reach the gym user — every limb is anchored to athletes.
• GLP-1s appear on no national doping annex checked. GH secretagogues engage both regimes.

Romania has the harshest import provision we found

Evidence tier: 1 — Legea 104/2008 consolidated, annex read item by item.

Article 14² of Legea 104/2008 makes bringing listed substances into Romania without authorisation an offence carrying two to seven years' imprisonment. Two features make it unusual.

First, it is more severe than domestic trafficking of the same substances — the act of importation is punished harder than selling once inside.

Second, the text does not carve out intra-EU movement. A parcel from Germany is, on the face of the provision, treated the same as one from outside the Union.

Romania also regulates gyms as premises: bodybuilding and fitness operators must hold an anti-doping operating certificate from ANAD, must notify ANAD of the supplements they sell, may not sell unsealed supplements, and committing a doping offence inside a gym or supplement shop is a statutory aggravating factor. We found no equivalent premises-licensing regime anywhere else in Europe.

One availability note that has no parallel elsewhere: Ozempic was withdrawn from the Romanian market from 1 August 2024, with diabetic patients moved to oral Rybelsus. This is secondary-sourced — we could not locate the ANMDMR primary — so treat it as reported rather than confirmed.

BPC-157 is not on the Romanian statutory annexes, which we read item by item.

Czechia: the lowest criminal threshold in Europe

Evidence tier: 1 — § 288 of the criminal code and the implementing annex read in full.

Czechia is rarely described as strict, and on this it is the strictest country in the study. Possession becomes criminal above a threshold of more than one vial or blister. That is not a trafficking quantity. It is roughly what a single course of anything comes in.

Czechia also diverges from Slovakia over four words. The Czech annex ends "a jejich uvolňující faktory" — and their releasing factors. The Slovak annex does not, and names no GHRH analogue, secretagogue or GHRP. On the enacted texts, GH-releasing peptides are caught in Czechia and apparently not in Slovakia, despite otherwise near-identical annexes.

Two caveats we will not bury. A 2025 draft amendment to the Czech annex exists, and we could not confirm whether it has been enacted — the "releasing factors" catch-all is load-bearing for everything above. And the current consolidated Slovak § 176 and its annex were also unresolved. Both should be re-checked before anyone relies on the Czech/Slovak contrast.

BPC-157 is not on the Czech annex or the Czech customs substance list.

Poland: the hand-carry allowance is a criminal boundary

Evidence tier: 1 — Article 68 Prawo farmaceutyczne and the 2017 doping act read directly.

Poland allows five packages hand-carried. What is easy to miss is that this is not merely a customs threshold.

Article 49(3) of the 2017 anti-doping act makes importing a WADA S1, S2 or S4 substance otherwise than in accordance with Article 68 of Prawo farmaceutyczne a criminal offence carrying up to three years. So the five-package allowance marks the edge of a crime, not the edge of a duty-free limit. Exceed it with a listed substance and the characterisation changes entirely.

Poland does not criminalise personal possession — the exposure is on the import act itself.

Poland also operates the hardest anti-export machinery in the region: a statutory listing under Article 37av(14) producing an outright export ban, with Ozempic in all three strengths, Trulicity and Suliqua on the list in force from 16 July 2026.

BPC-157 sits in WADA S0, so it falls outside Poland's criminal provisions, which reach S1, S2 and S4. The same gap appears in Hungary, whose provisions reach four named chemical categories.

Greece: severe on paper, narrow in reach

Evidence tier: 1 for the statute; the prohibited-substance list was not opened.

Greek doping law carries penalties up to ten years, which sounds like the strictest regime in Europe. Read the provision and it narrows sharply: *every limb of άρθρο 128Θ΄ is anchored to an athlete and to competition.* It largely does not reach a recreational gym user.

Two genuinely strange features. Greece criminalises possession for racehorses but not for humans. And it applies its doping law extraterritorially to Greek nationals even where the conduct was lawful where it took place.

Greece also requires registered athletes and support personnel to import *any pharmaceutical preparation or food supplement*** exclusively through EOF — not just doping substances, supplements too.

On reimbursement Greece is the exception in this group: it is the only country here where the state actually pays for GLP-1s in obesity, through the ΠΡΟΛΑΜΒΑΝΩ prevention programme, moved onto the EOPYY budget from 1 September 2026 with negotiated prices and rebates — while simultaneously locking Ozempic to diabetes. The Greek position is split by product, not by molecule class, which is easily lost in summary.

One blocking caveat. Whether ν. 4791/2021 amended, renumbered or replaced άρθρο 128Θ΄ is unresolved, and the entire Greek penalty position depends on it. We have not printed a penalties table for that reason.

Where possession is and is not a crime

Evidence tier: 1–2 — statutes read directly except where noted.

A trap for anyone researching Croatia. Much secondary commentary still quotes the pre-2018 Article 190(1), under which unauthorised possession of substances prohibited in sport carried up to six months. That provision was repealed. Anything citing article 190 for doping possession in Croatia is out of date.

What the regulators now say about "research chemicals"

Evidence tier: 1 — agency statements.

Three regulators in this region have addressed the research-use framing directly, and none of them accepts it.

Slovenia (JAZMP), 23 April 2026: "peptidi v oblikah za injiciranje se opredeljujejo kot zdravila" — injectable peptides are medicines.

Croatia (HZJZ), 2026: names semaglutide, retatrutide, somatropin, BPC-157, TB-500, CJC-1295, ipamorelin and MOTS-c, and stresses that an active substance appearing in an approved medicine does not make every product containing it approved.

Slovenia again, on enforcement: where sites are registered abroad with false data and rotate domains, the operators "cannot be identified, nor can they be sanctioned", and JAZMP's route is administrative minor-offence proceedings rather than criminal.

That last point is the practically important one, and it holds across the region. The realistic legal exposure falls on the domestic seller or reseller — including a private individual selling on classifieds or social media — not on the offshore site.

There is one documented worked example of an intercepted intra-EU parcel: Zagreb Police, 6 June 2018, a package sent by express post from Hungary, arrest on collection, and a dual charge — criminal complaint for unauthorised trade in substances prohibited in sport, plus a separate customs minor-offence charge for the unauthorised medicines in the same parcel.

Reimbursement, briefly

Evidence tier: 2 — several items secondary-sourced.

• Hungary gates by price rather than rule: Ozempic attracts 0% reimbursement on a GP prescription and 70% on a specialist prescription.
• Bulgaria reportedly closed NHIF semaglutide to new starters from 2025 while grandfathering existing patients — a cohort cut-off rather than an indication change, which is unusual.
• Slovenia's ZZZS found roughly 8% of Ozempic doses prescribed by physicians without the relevant specialisation.
• Slovakia lists Wegovy as registered, but reporting says it is not actually marketed, with the manufacturer directing users to Saxenda. Registration is not availability.
• Greece is the only state here funding GLP-1s for obesity, as described above.

What we could not verify

This region has the largest gaps in the series, and several are blocking.

• Greece: whether ν. 4791/2021 amended or replaced άρθρο 128Θ΄. The whole penalty position rests on it. Also the prohibited-substance list annexed under άρθρο 128Γ΄ — we make no claim about its contents.
• Czechia: whether the 2025 draft amendment to the annex was enacted.
• Slovakia: the current consolidated § 176 and annex. Whether possession is criminal, at what threshold, and whether releasing factors were added are all unresolved. We found no ŠÚKL page on personal import at all and did not fill the gap by analogy.
• Romania: Ordinul MS nr. 680/2003 in full — the only instrument governing medicines by post.
• Hungary: how customs treats postal consignments of medicines to private individuals. Nothing found in either direction.
• What customs actually does with an intercepted parcel in Poland, Hungary, Slovenia, Croatia, Romania, Bulgaria or Greece.
• National list contents for Greece, Bulgaria, Croatia and Slovenia. None were opened, so no peptide is named as listed in any of them.
• Telehealth prescribing across most of the region.

Limitations

This is educational content. It is not legal advice, and it is not medical advice.

• Several load-bearing items are unresolved, particularly for Greece, Czechia and Slovakia. Where we could not read the enacted text, we say so rather than infer.
• We describe what is lawful, not what to do. Nothing here is guidance on obtaining unapproved medicines, and we name no vendors or routes.
• We name no specific peptide as appearing on a national list unless that list was opened.
• Absence of a documented enforcement record is not evidence of lenient enforcement.
• Marko Maal, MSc Pharmacy reviewed this article. Reviewer attribution does not constitute a doctor-patient relationship.

The bottom line

If you take one thing from this page: the countries with the fearsome reputations are not the dangerous ones here. Greece's ten-year penalties are anchored to athletes and competition and largely miss the gym user. Czechia, which nobody warns about, criminalises possession above a single vial.

The two provisions most likely to catch someone out are Romania's Article 14², where importing listed substances carries two to seven years and is punished more harshly than trafficking with no visible intra-EU exception, and Poland's Article 49(3), which turns the five-package hand-carry allowance into the boundary of a criminal offence rather than a customs limit.

And the structural point that runs through the whole series holds here too. GLP-1s appear on no national doping annex we checked — their entire risk profile is medicines law, customs law and export control. GH secretagogues and GHRH analogues engage both regimes at once, and in Romania, Poland and Czechia the doping limb is by far the more severe of the two.

Related on this site

• Peptides in the Nordics: import rules and doping law
• Peptides in the Baltics: three different import rules
• Peptides in Benelux: the region that regulated the prescriber
• Are peptides legal in the European Union?
• BPC-157: animal vs human evidence reviewed
• Research-grade vs pharmaceutical-grade vs compounded peptides

References

• Romania: Legea 104/2008 consolidated to 2021, art. 14² (unauthorised import, 2–7 years) and Anexa nr. 1, read item by item. ANAD premises-certification regime for gyms and supplement retailers.
• Czechia: § 288 trestního zákoníku; nařízení vlády 454/2009 § 2 and Příloha č. 1 in full, including the "a jejich uvolňující faktory" clause; SÚKL/customs substance list of 30 May 2024.
• Slovakia: § 176 Trestného zákona as enacted 2015 and its annex — current consolidated text not obtained.
• Poland: art. 68 Prawo farmaceutyczne; arts. 48–49 of the 2017 anti-doping act (art. 49(3), import outside the art. 68 route, up to 3 years); anti-export list under art. 37av(14) in force from 16 July 2026; POLADA 2026 prohibited list.
• Greece: ν. 2725/1999 arts. 128Θ΄ and 128ΙΓ΄(8) as replaced by ν. 3708/2008. Whether ν. 4791/2021 further amended these is unverified.
• Hungary: Btk. § 185; WADA 2026 list as published by HUNADO.
• Slovenia: KZ-1 art. 186; FURS medicines page; JAZMP statement of 23 April 2026 that injectable peptides are medicines.
• Croatia: KZ art. 191.a via the government bill; Carinska uprava medicines page; HZJZ 2026 statement naming semaglutide, retatrutide, somatropin, BPC-157, TB-500, CJC-1295, ipamorelin and MOTS-c. Note art. 190 was repealed.
• Bulgaria: Наредба № 4/2009, Chapter Six, arts. 57–69. July 2025 Sofia Customs seizures were of steroids leaving Bulgaria in parcels mis-declared as office supplies.